FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jennifer Wilkinson-Berka

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Co-author Network

Publications

TOP 3
Jennifer L Wilkinson-Berka; Roksana Armani; Indrajeetsinh Rana; Alex Agrotis
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
Sih Min Tan; Jennifer L Wilkinson-Berka; Nada Stefanovic; Genevieve Tan; Judy B de Haan
Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice.
Mona Sedeek; Jennifer L Wilkinson-Berka; Mark E Cooper; Elyse Di Marco; Stephen P Gray; Richard L Hebert; Karin Jandeleit-Dahm; Jay C Jha; Augusto C Montezano; Ernesto L Schiffrin; Rhian M Touyz
Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jennifer Wilkinson-Berka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer L Wilkinson-Berka; Roksana Armani; Indrajeetsinh Rana; Alex Agrotis
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
Clinical science (London, England : 1979) 2013;124(10):597-615.
2013: Sih Min Tan; Jennifer L Wilkinson-Berka; Nada Stefanovic; Genevieve Tan; Judy B de Haan
Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice.
Investigative ophthalmology & visual science 2013;54(1):555-62.
2012: Mona Sedeek; Jennifer L Wilkinson-Berka; Mark E Cooper; Elyse Di Marco; Stephen P Gray; Richard L Hebert; Karin Jandeleit-Dahm; Jay C Jha; Augusto C Montezano; Ernesto L Schiffrin; Rhian M Touyz
Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.
Journal of cardiovascular translational research 2012;5(4):509-18.
2012: Jennifer L Wilkinson-Berka; Alex Agrotis; Devy Deliyanti
The retinal renin-angiotensin system: roles of angiotensin II and aldosterone.
Peptides 2012;36(1):142-50.
2012: Devy Deliyanti; Antonia G Miller; Andre L Samson; Genevieve Tan; Katrina J Binger; Jennifer L Wilkinson-Berka
Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.
Hypertension 2012;59(3):607-13.
2011: Jennifer L Wilkinson-Berka; G Perera; L Sutton; G Tan; K J Binger; D J Campbell; D Deliyanti; K McMaster; A G Miller
Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.
Diabetologia 2011;54(10):2724-35.
2011: Kirstan A Vessey; Jennifer L Wilkinson-Berka; Erica L Fletcher
Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy.
The Journal of comparative neurology 2011;519(3):506-27.
2011: Jennifer L Wilkinson-Berka; Antonia G Miller; Katrina J Binger
Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease.
Current opinion in nephrology and hypertension 2011;20(1):69-76.
2010: Antonia G Miller; Genevieve Tan; Katrina J Binger; Raelene Jane Pickering; Merlin C Thomas; Ram H Nagaraj; Mark E Cooper; Jennifer L Wilkinson-Berka
Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.
Diabetes 2010;59(12):3208-15.
2010: Erica L Fletcher; Joanna A Phipps; Michelle M Ward; Kirstan A Vessey; Jennifer L Wilkinson-Berka
The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature.
Progress in retinal and eye research 2010;29(4):284-311.
2010: Jennifer L Wilkinson-Berka; Ronen Heine; Genevieve Tan; Mark E Cooper; Kate M Hatzopoulos; Erica L Fletcher; Katrina J Binger; Duncan J Campbell; Antonia G Miller
RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina.
Hypertension 2010;55(6):1454-60.
2010: Erica L Fletcher; Laura E Downie; Kate Hatzopoulos; Kirstan A Vessey; Michelle M Ward; Chee L Chow; Michael J Pianta; Algis Vingrys; Michael Kalloniatis; Jennifer L Wilkinson-Berka
The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy.
Documenta ophthalmologica. Advances in ophthalmology 2010;120(1):67-86.
2010: Jennifer L Wilkinson-Berka; Antonia G Miller; Erica L Fletcher
Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Frontiers in bioscience (Elite edition) 2010;2():1054-64.
2010: Laura E Downie; Kate M Hatzopoulos; Michael J Pianta; Algis Vingrys; Jennifer L Wilkinson-Berka; Michael Kalloniatis; Erica L Fletcher
Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity.
The Journal of comparative neurology 2010;518(1):41-63.
2009: Jennifer L Wilkinson-Berka; Duncan J Campbell
(Pro)renin receptor: a treatment target for diabetic retinopathy?
Diabetes 2009;58(7):1485-7.
2009: L E Downie; Kirstan A Vessey; A Miller; Michelle M Ward; Michael J Pianta; Algis Vingrys; Jennifer L Wilkinson-Berka; Erica L Fletcher
Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina.
Neuroscience 2009;161(1):195-213.
2009: Jennifer L Wilkinson-Berka; Genevieve Tan; Kassie Jaworski; Antonia G Miller
Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Circulation research 2009;104(1):124-33.
2008: Jennifer L Wilkinson-Berka
Prorenin and the (pro)renin receptor in ocular pathology.
The American journal of pathology 2008;173(6):1591-4.
2008: Laura E Downie; Michael J Pianta; Algis Vingrys; Jennifer L Wilkinson-Berka; Erica L Fletcher
AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy.
Glia 2008;56(10):1076-90.
2008: Jennifer L Wilkinson-Berka; Antonia G Miller
Update on the treatment of diabetic retinopathy.
TheScientificWorldJournal 2008;8():98-120.
2007: Laura E Downie; Michael J Pianta; Algis Vingrys; Jennifer L Wilkinson-Berka; Erica L Fletcher
Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.
The Journal of comparative neurology 2007;504(4):404-17.
2007: Darren J Kelly; Jennifer L Wilkinson-Berka; Richard E Gilbert
Progressive diabetic nephropathy in the Ren-2 rat.
American journal of physiology. Renal physiology 2007;292(5):F1662; author reply F1663.
2007: Jennifer L Wilkinson-Berka; Genevieve Tan; Kassie Jaworski; Slavisa Ninkovic
Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina.
American journal of hypertension 2007;20(4):423-30.
2007: Joanna A Phipps; Jennifer L Wilkinson-Berka; Erica L Fletcher
Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
Investigative ophthalmology & visual science 2007;48(2):927-34.
2007: Erica L Fletcher; Joanna A Phipps; Michelle M Ward; Theresa Puthussery; Jennifer L Wilkinson-Berka
Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.
Current pharmaceutical design 2007;13(26):2699-712.
2007: Jennifer L Wilkinson-Berka; Shari Lofthouse; Kassie Jaworski; Slavisa Ninkovic; George Tachas; Christopher J Wraight
An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.
Molecular vision 2007;13():1529-38.
2006: Jennifer L Wilkinson-Berka; Daria Jones; George Taylor; Kassie Jaworski; Darren J Kelly; Steve B Ludbrook; Robert N Willette; Sanjay Kumar; Richard E Gilbert
SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Investigative ophthalmology & visual science 2006;47(4):1600-5.
2006: Jennifer L Wilkinson-Berka; Christopher J Wraight; George Werther
The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.
Current medicinal chemistry 2006;13(27):3307-17.
2006: Jennifer L Wilkinson-Berka
Angiotensin and diabetic retinopathy.
The international journal of biochemistry & cell biology 2006;38(5-6):752-65.
2005: Darren J Kelly; Jennifer L Wilkinson-Berka; Richard E Gilbert
Renin inhibition: new potential for an old therapeutic target.
Hypertension 2005;46(3):471-2.
2005: Philip B Bergman; Christina Moravski; Stephanie Edmondson; Vincenzo Russo; Leon A Bach; Jennifer L Wilkinson-Berka; George Werther
Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
Investigative ophthalmology & visual science 2005;46(8):2708-15.
2005: Erica L Fletcher; Joanna A Phipps; Jennifer L Wilkinson-Berka
Dysfunction of retinal neurons and glia during diabetes.
Clinical & experimental optometry : journal of the Australian Optometrical Association 2005;88(3):132-45.
2005: Stella Sarlos; Jennifer L Wilkinson-Berka
The renin-angiotensin system and the developing retinal vasculature.
Investigative ophthalmology & visual science 2005;46(3):1069-77.
2005: Jennifer Martin; Darren J Kelly; Sally A Mifsud; Yuan Zhang; Alison J Cox; Fiona See; Henry Krum; Jennifer L Wilkinson-Berka; Richard E Gilbert
Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta.
Cardiovascular research 2005;65(3):694-701.
2004: Jennifer L Wilkinson-Berka
Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
Expert reviews in molecular medicine 2004;6(15):1-18.
2004: Jennifer L Wilkinson-Berka; Sanja Babic; Tanyth E De Gooyer; Alan Stitt; Kassie Jaworski; Leslie G T Ong; Darren J Kelly; Richard E Gilbert
Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy.
The American journal of pathology 2004;164(4):1263-73.
2004: Darren J Kelly; Alicia N Stein-Oakley; Yuan Zhang; Lesley Wassef; Julie Maguire; Takehiko Koji; Napier Thomson; Jennifer L Wilkinson-Berka; Richard E Gilbert
Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.
Nephrology (Carlton, Vic.) 2004;9(1):7-13.
2004: Tanyth E De Gooyer; Sandford L Skinner; Mary E Wlodek; Darren J Kelly; Jennifer L Wilkinson-Berka
Angiotensin II influences ovarian follicle development in the transgenic (mRen-2)27 and Sprague-Dawley rat.
The Journal of endocrinology 2004;180(2):311-24.
2004: Jennifer L Wilkinson-Berka
Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.
Current pharmaceutical design 2004;10(27):3331-48.
2004: Jennifer L Wilkinson-Berka; Erica L Fletcher
Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.
Current pharmaceutical design 2004;10(27):3313-30.
2004: Sally A Mifsud; Louise M Burrell; Eiji Kubota; Kassie Jaworski; Mark E Cooper; Jennifer L Wilkinson-Berka
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(1):69-80.
2003: Stella Sarlos; Bishoy Rizkalla; Christina Moravski; Zemin Cao; Mark E Cooper; Jennifer L Wilkinson-Berka
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.
The American journal of pathology 2003;163(3):879-87.
2003: Richard E Gilbert; H Krum; Jennifer L Wilkinson-Berka; D J Kelly
The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.
Diabetic medicine : a journal of the British Diabetic Association 2003;20(8):607-21.
2003: Maurice E Fabiani; David J Hawkes; Albert G Frauman; Chris Tikellis; Colin I Johnston; Jennifer L Wilkinson-Berka
Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibition.
The international journal of biochemistry & cell biology 2003;35(6):973-83.
2003: Jennifer L Wilkinson-Berka; Nicole S Alousis; Darren J Kelly; Richard E Gilbert
COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.
Investigative ophthalmology & visual science 2003;44(3):974-9.
2003: Darren J Kelly; Yuan Zhang; Claire Hepper; Renae M Gow; Kassie Jaworski; Bruce E Kemp; Jennifer L Wilkinson-Berka; Richard E Gilbert
Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Diabetes 2003;52(2):512-8.
2003: Sally A Mifsud; Darren J Kelly; Weier Qi; Yuan Zhang; Carol A Pollock; Jennifer L Wilkinson-Berka; Richard E Gilbert
Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
Nephron. Physiology 2003;95(4):p83-91.
2003: Christina Moravski; Sandford L Skinner; Anthony J Stubbs; Stella Sarlos; Darren J Kelly; Mark E Cooper; Richard E Gilbert; Jennifer L Wilkinson-Berka
The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
The American journal of pathology 2003;162(1):151-60.
2002: Jennifer L Wilkinson-Berka; Darren J Kelly; Suzanne M Koerner; Kassie Jaworski; Belinda Davis; Vicki Thallas; Mark E Cooper
ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Diabetes 2002;51(11):3283-9.
2002: Jennifer L Wilkinson-Berka; Darren J Kelly; Pei Rong; Duncan J Campbell; Sandford L Skinner
Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat.
Molecular and cellular endocrinology 2002;194(1-2):201-9.
2002: Darren J Kelly; Jennifer L Wilkinson-Berka; Sharon D Ricardo; Alison J Cox; Richard E Gilbert
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(6):985-91.
2002: Sally A Mifsud; Sandford L Skinner; Mark E Cooper; Darren J Kelly; Jennifer L Wilkinson-Berka
Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.
Journal of the American Society of Nephrology : JASN 2002;13(3):684-92.
2002: Darren J Kelly; Alison J Cox; Mary Tolcos; Mark E Cooper; Jennifer L Wilkinson-Berka; Richard E Gilbert
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Kidney international 2002;61(1):31-9.
2001: Jennifer L Wilkinson-Berka; Darren J Kelly; Richard E Gilbert
The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
Journal of vascular research 2001;38(6):527-35.
2001: Sally A Mifsud; Terri J Allen; John F Bertram; UL Hulthen; Darren J Kelly; Mark E Cooper; Jennifer L Wilkinson-Berka; Richard E Gilbert
Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
Diabetologia 2001;44(7):878-82.
2001: Jennifer L Wilkinson-Berka; N J Gibbs; Mark E Cooper; Sandford L Skinner; Darren J Kelly
Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(7):1343-9.
2001: Pei Rong; Jennifer L Wilkinson-Berka; Sandford L Skinner
Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats.
Molecular and cellular endocrinology 2001;173(1-2):203-12.
2001: R E Gilbert; Jennifer L Wilkinson-Berka; Darren J Kelly
Angiotensin and renal fibrosis.
Contributions to nephrology 2001;(135):171-86.
2000: Christina Moravski; Darren J Kelly; Mark E Cooper; Richard E Gilbert; John F Bertram; S Shahinfar; Sandford L Skinner; Jennifer L Wilkinson-Berka
Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
Hypertension 2000;36(6):1099-104.
2000: Richard E Gilbert; Darren J Kelly; Alison J Cox; Jennifer L Wilkinson-Berka; Jon R Rumble; Tanya M Osicka; Sianna Panagiotopoulos; V Lee; EC Hendrich; George Jerums; Mark E Cooper
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Diabetologia 2000;43(11):1360-7.
2000: Aphrodite Caragounis; Kathy Koutsis; Mary E Wlodek; Jennifer L Wilkinson-Berka; Robert Di Nicolantonio
First report of active renin in rat amniotic fluid.
Clinical and experimental pharmacology & physiology 2000;27(8):631-3.
2000: Darren J Kelly; Sandford L Skinner; Richard E Gilbert; Alison J Cox; Mark E Cooper; Jennifer L Wilkinson-Berka
Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
Kidney international 2000;57(5):1882-94.
1999: Pei Rong; Jennifer L Wilkinson-Berka; Sandford L Skinner
Renin in thymus, gut, hindlimb, and adrenal of (mRen-2)27 and normal rats: secretion and content studies.
The American journal of physiology 1999;277(4 Pt 1):E639-46.
1999: Pei Rong; Jennifer L Wilkinson-Berka; Sandford L Skinner
Potassium control of extrarenal renin secretion in transgenic (mRen-2)27 and normal rats.
The American journal of physiology 1999;277(4 Pt 1):E631-8.
1999: Richard E Gilbert; L L Wu; Darren J Kelly; A Cox; Jennifer L Wilkinson-Berka; Colin I Johnston; Mark E Cooper
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis.
The American journal of pathology 1999;155(2):429-40.
1999: D J Campbell; Darren J Kelly; Jennifer L Wilkinson-Berka; Mark E Cooper; Sandford L Skinner
Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.
Kidney international 1999;56(1):211-21.
1999: Richard E Gilbert; Alison J Cox; Darren J Kelly; Jennifer L Wilkinson-Berka; E H Sage; George Jerums; Mark E Cooper
Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye.
Connective tissue research 1999;40(4):295-303.
1998: Richard E Gilbert; Jennifer L Wilkinson-Berka; D W Johnson; Alison Cox; T Soulis; LL Wu; Darren J Kelly; George Jerums; Carol A Pollock; Mark E Cooper
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.
Kidney international 1998;54(4):1052-62.
1998: Darren J Kelly; Jennifer L Wilkinson-Berka; Terri J Allen; Mark E Cooper; Sandford L Skinner
A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).
Kidney international 1998;54(2):343-52.